Table 4 |
|||||
|
Outcomes for all patients and for patients classified according to the maximum Risk, Injury, Failure, Loss, and End-stage Kidney (RIFLE) class |
|||||
|
No acute kidney injury (n = 1,766) |
Risk (n = 670) |
Injury (n = 1,436) |
Failure (n = 1,511) |
All injury (n = 5,383) |
|
|
|
|||||
|
Renal replacement therapy* |
1 (0.1%) |
0 (0%) |
4 (0.3%) |
214 (14.2%) |
219 (4.1%) |
|
Hospital LOS after reaching maximum RIFLE class (days)* |
5 (3–10) |
5 (3–10) |
7 (4–14) |
11 (5–23) |
7 (3–14) |
|
ICU LOS (days)* |
3 (2–4) |
3 (2–6) |
5 (3–10) |
9 (4–21) |
4 (2–9) |
|
Hospital LOS (days)* |
6 (4–10) |
8 (5–14) |
10 (6–19) |
16 (9–31) |
9 (5–19) |
|
Hospital mortality* |
97 (5.5%) |
59 (8.8%) |
163 (11.4%) |
398 (26.3%) |
717 (13.3%) |
|
|
|||||
|
Continuous variables presented as the median (interquartile interval) and categorical variables presented as the percentage. LOS, length of stay; ICU, intensive care unit. *P = 0.001 between the four subgroups no acute kidney injury, RIFLE class risk, RIFLE class injury and RIFLE class failure. |
|||||
|
Hoste et al. Critical Care 2006 10:R73 doi:10.1186/cc4915 |
|||||